Adiponectin has been widely studied as a promising therapeutic tool for T2DM and metabolic syndrome management, as it exerts anti-diabetic, anti-inflammatory and anti-atherogenic actions [19]. This evidence concerns the gene ADIPOQ and type 2 diabetes mellitus.